ConductScience.org, home

Paper35675433

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.

Jennings D and 38 others. Sci Transl Med, 2022. Cited by 203 papers, by iCite.

Cite this record

ConductScience Library. Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease. Papers, record 35675433. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35675433

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease.
PubMed
Journal
Sci Transl Med
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
203
iCite
Relative citation ratio, by iCite
16.3
iCite
Revised in PubMed
2022-10-25
PubMed

Authors39

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

See all 39 authorsDownload CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Major topic
Parkinson DiseaseMajor topic
Animals
Humans
Lysosomes
Mice
Mutation
Phosphorylation

Source PubMed

Download CSV of topics

Comments and corrections3

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn PapersSource
Comment in35675432A step forward for LRRK2 inhibitors in Parkinson's disease.https://conductscience.org/library/papers/35675432PubMed
Comment in35804045LRRK2 inhibitor progresses for Parkinson disease.https://conductscience.org/library/papers/35804045PubMed
Comment in36260987Targeting LRRK2 in Parkinson's disease.https://conductscience.org/library/papers/36260987PubMed

Download CSV of comments and corrections

Cited by139

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 203 citations.

PMIDTitleJournalYearIn PapersSource
42983584Brain clearance of protein aggregates in degenerative diseases: the role of microglia and astrocytes.Transl Neurodegener2026https://conductscience.org/library/papers/42983584PubMed
42959345Disease-guided targeted protein degradation and clearance: matching strategies to pathological protein states.Front Med (Lausanne)2026https://conductscience.org/library/papers/42959345PubMed
42836964Does genetic testing remain relevant in advanced Parkinson's disease?J Neural Transm (Vienna)2026https://conductscience.org/library/papers/42836964PubMed
42818643Chemical Genetic Targeting of the LRRK2 GTPase Domain.bioRxiv2026https://conductscience.org/library/papers/42818643PubMed
42776440Neuroprotection Across Cerebellar and Nigrostriatal Degeneration: Translational Insights from Parkinson's Disease to Spinocerebellar Ataxia Type 2.Cerebellum2026https://conductscience.org/library/papers/42776440PubMed
42737506LRRK2: Molecular Mechanisms in Parkinson's Disease.Int J Mol Sci2026https://conductscience.org/library/papers/42737506PubMed
42714656Therapeutics candidates and repurposing strategies to target parkinson's disease pathology: current evidence and future directions.Metab Brain Dis2026https://conductscience.org/library/papers/42714656PubMed
42660892Leucine-rich repeat kinase 2 impairs the release sites of Parkinson's disease vulnerable dopamine axons.Nat Commun2026https://conductscience.org/library/papers/42660892PubMed
42630748Subtype-specific secretion of extracellular vesicles by LRRK2 and Rab GTPases under lysosomal stress.iScience2026https://conductscience.org/library/papers/42630748PubMed
42599550Astrocytes orchestrate neuroprotection and pathogenesis via bidirectional neuronal interactions in Parkinson's disease.J Physiol Biochem2026https://conductscience.org/library/papers/42599550PubMed
42552442XunZi, an AI biologist, reveals disease-modifying targets.Nat Biomed Eng2026https://conductscience.org/library/papers/42552442PubMed
42489942From synaptic development to degeneration: a narrative review of small molecule strategies targeting alpha-synuclein in Parkinson's disease.Metab Brain Dis2026https://conductscience.org/library/papers/42489942PubMed
42449370Parkinson's disease as a multi-axis systems disorder: integrating molecular pathology and circuit-level therapeutics.Cell Commun Signal2026https://conductscience.org/library/papers/42449370PubMed
42396337Large-scale functional annotation establishes a reference framework for human LRRK2 variants.medRxiv2026https://conductscience.org/library/papers/42396337PubMed
42310464Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource.Nature2026https://conductscience.org/library/papers/42310464PubMed
42270888Robust analytical methods for bis(monoacylglycero)phosphate profiling in health and disease.Nat Protoc2026https://conductscience.org/library/papers/42270888PubMed
42233523Leucine-rich repeat kinase 2 (LRRK2): balancing cellular homeostasis and Parkinson's disease (PD) pathogenesis.Ann Med2026https://conductscience.org/library/papers/42233523PubMed
42187233Parkinson's disease drug therapies in the clinical trial pipeline: 2015-2024.J Parkinsons Dis2026https://conductscience.org/library/papers/42187233PubMed
42179585Synthesis and Preclinical Evaluation of [11C]GNE-0877 as a Potential PET Radioligand for Imaging Brain Leucine-Rich Repeat Kinase 2.ACS Omega2026https://conductscience.org/library/papers/42179585PubMed
42177293Proximity proteomics reveals a co-evolved LRRK2-regulatory network linked to centrosomes.EMBO Rep2026https://conductscience.org/library/papers/42177293PubMed

See all 139 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
LRRK2120892PubTator's text mininghttps://conductscience.org/library/genes/120892NCBI Gene
RAB1010890PubTator's text mininghttps://conductscience.org/library/genes/10890NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35675433

GET https://conductscience.org/api/papers/v1/35675433/authors?page=2